Ebola Is Spreading. Why Isn't America Responding?

Key Takeaways

• Bundibugyo Ebola cases in Ituri exceed previous outbreaks combined
• USAID closure removed $12.7 B in global health funding
• No DART coordination; PPE shortages reported within two days
• Africa CDC leads response, but resources remain limited
• Private donors alone cannot replace U.S. donor capacity

Pulse Analysis

The Ituri outbreak highlights a pivotal shift in global health architecture. Since the 2025 shutdown of USAID, the United States has withdrawn roughly $12.7 billion in funding that once underpinned the Disaster Assistance Response Team, a joint operation of CDC, State, Defense and HHS. That dismantling stripped away a rapid‑deployment logistics network and a coordinated command structure, leaving Africa CDC to shoulder the bulk of the response. While the continental agency has matured—activating a 72‑hour incident plan and deploying surge teams—it now grapples with PPE gaps and a fragmented supply chain that previously relied on U.S. contractors.

Compounding the logistical shortfall is the nature of the Bundibugyo strain itself. Unlike the Zaire variant, Bundibugyo lacks an approved vaccine or monoclonal antibody therapy, forcing responders to depend on classic non‑pharmaceutical interventions such as contact tracing, safe burials and infection‑prevention measures. The outbreak’s epicenter in mining towns and the provincial capital Bunia, coupled with ongoing armed conflict and massive displacement, creates a volatile environment where traditional containment tools are stretched thin. Early detection lagged three weeks, allowing silent transmission chains to seed neighboring Uganda and potentially South Sudan.

The broader implications extend beyond the immediate crisis. The erosion of U.S. donor capacity has left a vacuum that private philanthropy and limited European aid cannot fully fill. As Africa‑led mechanisms assume greater responsibility, the margin for error narrows, raising concerns for future filovirus events. Strengthening regional supply chains, securing dedicated funding streams, and re‑establishing a coordinated multinational response framework are essential to prevent the next outbreak from spilling over into global markets, including the United States.